| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2007;49:473.)
© 2007 American Heart Association, Inc.
Original Articles |
From the Department of Pharmacology and Toxicology (V.A.M.v.d.S., S.W.M.v.d.B., A.E.S., B.J.A.J., J.F.M.S., W.M.B.), Cardiovascular Research Institute Maastricht, Department of Respiratory Medicine (J.L.J.v.d.V., R.C.J.L.), Maastricht University, Maastricht, the Netherlands; and Howard Hughes Medical Institute (A.W.-B.), University of California, San Diego.
Correspondence to W. Matthijs Blankesteijn, Department of Pharmacology and Toxicology, CARIM, Maastricht University, PO Box 616, 6200 MD Maastricht, the Netherlands. E-mail Wm.Blankesteijn{at}FARMACO.unimaas.nl
The hypertrophic response of the heart has been recognized recently as the net result of activation of prohypertrophic and antihypertrophic pathways. Here we report the involvement of the Wnt/Frizzled pathway in the onset of cardiac hypertrophy development. Stimulation of the Wnt/Frizzled pathway activates the disheveled (Dvl) protein. Disheveled subsequently can inhibit glycogen synthase kinase-3ß, a protein with potent antihypertrophic actions through diverse molecular mechanisms. In the Wnt/Frizzled pathway, inhibition of glycogen synthase kinase-3ß leads to an increased amount of ß-catenin, which can act as a transcription factor for several hypertrophy-associated target genes. In this study we subjected mice lacking the Dvl-1 gene and their wild-type littermates to thoracic aortic constriction for 7, 14, and 35 days. In mice lacking the Dvl-1 gene, 7 days of pressure overload-induced increases in left ventricular posterior wall thickness and expression of atrial natriuretic factor and brain natriuretic protein were attenuated compared with their wild-type littermates. ß-Catenin protein amount was reduced in the group lacking the Dvl-1 gene, and an increased glycogen synthase kinase-3ß activity was observed. Moreover, the increase in the amount of Ser473-phosphorylated Akt, a stimulator of cardiac hypertrophy, was lower in the group lacking the Dvl-1 gene. In conclusion, we have demonstrated that interruption of Wnt signaling in the mice lacking the Dvl-1 gene attenuates the onset of pressure overload-induced cardiac hypertrophy through mechanisms involving glycogen synthase kinase-3ß and Akt. Therefore, the Wnt/Frizzled pathway may provide novel therapeutic targets for antihypertrophic therapy.
Key Words: hypertrophy Wnt cell signaling glycogen synthase kinase-3ß Akt
Related Article:
Hypertension 2007 49: 427-428.
This article has been cited by other articles:
![]() |
E. D. Cohen, Y. Tian, and E. E. Morrisey Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal Development, March 1, 2008; 135(5): 789 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Force, K. Woulfe, W. J. Koch, and R. Kerkela Molecular Scaffolds Regulate Bidirectional Crosstalk Between Wnt and Classical Seven-Transmembrane Domain Receptor Signaling Pathways Sci. Signal., July 31, 2007; 2007(397): pe41 - pe41. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. H. Cingolani Cardiac Hypertrophy and the Wnt/Frizzled Pathway Hypertension, March 1, 2007; 49(3): 427 - 428. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |